$USAC

USA Compression Partners, LP (USAC): Results of Operations and Financial Condition

USA Compression Partners, LP (USAC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release USA Compression Partners, LP 8115 Preston Road, Suite 700 Dallas, Texas 75225 usacompression.com USA Compression Partners Reports Second-Quarter 2026 Results DALLAS, Texas, August 4, 2026 — USA Compression Partners, LP (NYSE: USAC) (“USA Compression” or

Original reporting
Published Aug 4, 2026, 11:02 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 11:33 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$USAC
Bullish
medium confidence
Mentioned
$USAC
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$USACBullishMed
01

Why it matters

Traders can update expectations for distribution sustainability and credit comfort using the reported distributable cash flow, coverage ratio, and covenant/credit availability, alongside the confirmed full-year outlook ranges.

02

Market read

Q2 cash-flow and coverage improved year-over-year, and the company confirmed full-year 2026 adjusted EBITDA and distributable cash flow ranges, which are directly relevant to unit-holder expectations.

03

What to watch

The filing highlights large horsepower on order (97,650) and delivery timing, but does not quantify customer credit risk or any potential cost inflation; those could affect margins and coverage beyond the guidance ranges.

Relevance 7/10Novelty 8/10Timing: filed pre-market today (Aug 4, 2026) with Q2 results and full-year guidance

Background

This is an SEC Form 8-K with Exhibit 99.1 reporting USA Compression Partners’ second-quarter 2026 financial and operating results and reaffirming full-year 2026 guidance.

Company-level read

Ticker impact

$USACBullishMedium confidence
Context

USAC reported Q2 2026 results with revenues of $342.1M, net income of $45.7M, and distributable cash flow of $125.3M.

Expected impact

Likely modest positive bias for the next session as investors digest stronger Q2 cash flow and a maintained 2026 outlook.

Evidence & confidence

Q2 shows year-over-year improvement across revenues, net income, adjusted EBITDA, and distributable cash flow coverage (1.65x vs 1.40x). The company also confirms full-year 2026 guidance ranges, and states covenant compliance with remaining revolver availability.

Market effects

Improved utilization and contracted horsepower metrics can be read across to natural gas compression infrastructure demand expectations.

No specific regional demand shock is disclosed; impact is primarily company-specific.

Limited global relevance; the story is tied to US natural gas infrastructure contracting and financing.

Counterpoint

Despite higher Q2 distributable cash flow, utilization fell slightly versus prior quarter and expansion capex remains elevated, which could pressure future free cash flow if contracting slows.

Key entities

  • USA Compression Partners, LP

    Reports Q2 2026 results, distributable cash flow, and confirms full-year 2026 guidance in an 8-K.

  • Clint Green

    CEO quoted on integration progress and contracted horsepower momentum.

Related articles

$USACMed

United States Antimony Corporation Q2 2026 Earnings Call Summary

United States Antimony Corp. reported Q2 2026 revenue down 25% year over year, driven mainly by a 52% fall in realized antimony prices. The company is building $21.6M inventory for its sole-source DLA contract and raised zeolite segment revenue 110%. Full-year 2026 revenue guidance was cut to $60-$75M due to lower pricing; it has $62.2M cash plus a $43.2M Larvotto equity stake.

$USACMed

USA Compression Partners Q2 Earnings Call Highlights

USA Compression Partners (NYSE:USAC) reported Q2 metrics including 4.95 million total fleet horsepower, 92% utilization, and average revenue per revenue-generating horsepower per month of $22.84. Adjusted gross margin was 63.5% and leverage was 3.72x. The firm reaffirmed 2026 outlook for adjusted EBITDA $770m-$800m and distributable cash flow $480m-$510m, plus capex guidance.

$IBKRMedAI 8/10

Interactive Brokers Earns Interest on $182 Billion of Its Clients' Idle Cash. Will Anthropic's IPO Drain It?

Interactive Brokers (IBKR) reported $182.4B in uninvested client cash, up 27% YoY, earning interest until invested. Anthropic's potential $2T IPO could impact cash levels, but SpaceX's IPO didn't drain IBKR's reserves. IBKR's Q2 net interest income rose 23% to $1.06B, half of total revenues. Client accounts and trading activity grew, mitigating cash outflows. IBKR stock is near $92, trading at 29x next year's earnings.

$ORCLMedAI 8/10

Oracle’s AI Earnings Story Is Improving, but the Cash Flow Test Remains

Oracle (ORCL) reported strong Q4 earnings with 21% revenue growth and raised its profit forecast. Morgan Stanley increased its price target to $210, citing improved GPUaaS margins. However, the company faces cash flow pressure due to high capital expenditures for AI infrastructure, with free cash flow at negative $23.7 billion. Hedge funds remain invested, with Fisher Asset Management increasing its stake.

$AVGOMedAI 9/10

Broadcom’s AI Forecast Suggests Hyperscalers Want More Than Just Nvidia GPUs

Broadcom (AVGO) raised its AI chip revenue forecast to $115B for FY2027, up from $100B, and expects $230B in FY2028. This reflects Big Tech's demand for custom chips and networking components, reducing reliance on Nvidia (NVDA). KeyBanc reiterated an Overweight rating and $575 price target for AVGO. AVGO's Q3 revenue rose 86% YoY to $29.6B, but Q4 guidance was slightly below expectations. Hedge funds hold positions in both AVGO and NVDA, with Fisher Asset Management among the top holders.